Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-<sc>l</sc>- Norleucine in Mice with Alphavirus Encephalomyel
6-Diazo-5-oxo-L-norleucine - Wikipedia
Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs | Journal of Medicinal Chemistry
6-diazo-5-oxo-L-norleucine | C6H9N3O3 - PubChem
Model studies towards prodrugs of the glutamine antagonist 6-diazo-5-oxo-l- norleucine (DON) containing a diazo precursor - ScienceDirect
6-diazo-5-oxo-L-nor-Leucine (DON, NSC 7365, CAS Number: 157-03-9) | Cayman Chemical
Glutamine deficiency induces DNA alkylation damage and sensitizes cancer cells to alkylating agents through inhibition of ALKBH enzymes | PLOS Biology
6-Diazo-5-oxo-L-norleucine | ≥99%(HPLC) | Selleck | Glutaminase antagonist
A mechanism behind the antitumour effect of 6-diazo-5-oxo-l-norleucine (DON): disruption of mitochondria - European Journal of Cancer
WO2016112386A1 - Methods for bioanalysis of 6-diazo-5-oxo-l-norleucine (don) and other glutamine antagonists - Google Patents
Discovery of 6-Diazo-5-oxo-l-norleucine (DON) Prodrugs with Enhanced CSF Delivery in Monkeys: A Potential Treatment for Glioblastoma | Journal of Medicinal Chemistry
The combination of orlistat, lonidamine and 6‑diazo‑5‑oxo‑L‑norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells
6-Diazo-5-oxo-L-norleucine-cancer research-TOKU-E
6-Diazo-5-oxo-L-norleucine - Wikipedia
Evaluating the toxicity of the analgesic glutaminase inhibitor 6-diazo-5-oxo -l-norleucine in vitro and on rat dermal skin fibroblasts - MedCrave online
Model studies towards prodrugs of the glutamine antagonist 6-diazo-5-oxo-l- norleucine (DON) containing a diazo precursor - ScienceDirect
N-(Pivaloyloxy)alkoxy-carbonyl Prodrugs of the Glutamine Antagonist 6-Diazo- 5-oxo-l-norleucine (DON) as a Potential Treatment fo
6-Diazo-5-oxo-L-norleucine - Wikipedia
Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-<sc>l</sc>- Norleucine in Mice with Alphavirus Encephalomyel
6-Diazo-5-oxo-L-Norleucine | VWR
The combination of orlistat, lonidamine and 6‑diazo‑5‑oxo‑L‑norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells
Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs | Journal of Medicinal Chemistry
l-asparaginase and 6-diazo-5-oxo-l-norleucine synergistically inhibit the growth of glioblastoma cells | SpringerLink
6-Diazo-5-oxo- L -norleucine crystalline 157-03-9
